跳至主要内容
临床试验/PACTR202004723570110
PACTR202004723570110已完成未知

Effectiveness of Fiberoptic Phototherapy Compared to Conventional Phototherapy in Treating Hyperbilirubinemia Amongst Term Neonates Receiving Care at Kilimanjaro Christian Medical Centre

Helvi N Joel0 个研究点目标入组 39 人开始时间: 2020年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
39

研究概览

简要总结

In our study, phototherapy was effective in decreasing bilirubin levels in all three groups. The response was greater in the blue light conventional phototherapy (0.84%/h), followed by fiberoptic phototherapy (0.74%/h), whereas the white light conventional phototherapy (0.29%/h) had the lowest response in lowering serum bilirubin levels. The effectiveness of fiberoptic PT and blue light conventional PT were comparable in terms of bilirubin reduction rate and treatment duration, whereas fiberoptic phototherapy was more effective than white light conventional PT, with a significantly lower bilirubin reduction rate and treatment duration. No side effects were reported in the fiberoptic PT group, while both conventional PT groups reported loose stool. A transient erythematous skin rash was noted with blue light conventional PT.

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Day(s) 至 1 Month(s)(—)
性别
All

入选标准

  • All term neonates (>37 weeks of gestation),
  • less than 7 days of age,
  • with unconjugated hyperbilirubinemia with a total bilirubin level that has reached phototherapy threshold values as per the American Academy of Pediatrics (AAP) nomogram values.

排除标准

  • Newborns receiving phenobarbitone.
  • Newborns with bilirubin levels that have reached exchange transfusion levels on the AAP nomogram.
  • Newborns with conjugated hyperbilirubinaemia.
  • Newborns who have already received phototherapy prior to enrollment.
  • Newborns whose parents refused to consent.

研究者

发起方
Helvi N Joel

相似试验